Request Demo
Last update 24 May 2025
Choline Fenofibrate/Rosuvastatin Calcium
Last update 24 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ABT-335/rosuvastatin, Certriad, Choline-Fenofibrate/Rosuvastatin + [4] |
Target |
Action inhibitors, agonists |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC22H28CaFN3O6S |
InChIKeyAVDMILNVMOXCHF-DHMAKVBVSA-N |
CAS Registry147098-20-2 |
View All Structures (2)
Related
8
Clinical Trials associated with Choline Fenofibrate/Rosuvastatin CalciumCTRI/2014/02/004417
A Randomized, Open Label, Multicentre, Comparative Clinical Trial of IN-SUPR-002 in Comparison with Fixed Dose Combination (FDC) of Fenofibrate and Rosuvastatin in Patients with Mixed Dyslipidemia - NA
NCT00808678
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium
NCT00826358
Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
100 Clinical Results associated with Choline Fenofibrate/Rosuvastatin Calcium
Login to view more data
100 Translational Medicine associated with Choline Fenofibrate/Rosuvastatin Calcium
Login to view more data
100 Patents (Medical) associated with Choline Fenofibrate/Rosuvastatin Calcium
Login to view more data
100 Deals associated with Choline Fenofibrate/Rosuvastatin Calcium
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | NDA/BLA | United States | - | - |
| Hyperlipidemias | NDA/BLA | - | - | |
| Hyperlipidemias | NDA/BLA | - | - | |
| Hypercholesterolemia | Phase 3 | United States | 01 Nov 2008 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 474 | (Simvastatin Capsules 40 mg) | tikhnwrqbf(ahpkgonycb) = mmamzwsnfk ruiiqirbqp (vpejkorcqf, 1.59) View more | - | 01 Aug 2012 | ||
(ABT-143 Capsules 20/135 mg) | tikhnwrqbf(ahpkgonycb) = wfeafuvqfg ruiiqirbqp (vpejkorcqf, 1.60) View more | ||||||
Phase 3 | 760 | (ABT-335 and Rosuvastatin Calcium) | oyiidehfpm(nmqsgdbruy) = sfoegawmim ubazgvtzog (bxswpbqadr, 1.33) View more | - | 01 Aug 2012 | ||
(Rosuvastatin Calcium) | oyiidehfpm(nmqsgdbruy) = dmiizyhoez ubazgvtzog (bxswpbqadr, 1.32) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free